Semaglutide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen
AUST R: 308324
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

From
15 Apr 2022
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/update-ozempic-supply-remain-limited-2025. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen
AUST R: 315107
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

From
15 Apr 2022
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
An updated TGA web statement is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/update-ozempic-supply-remain-limited-2025. Unregistered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals